|
|
| |
Basic InformationMore InformationLatest NewsAlzheimer's May Strike Women and Men in Different WaysHistory of Mental Illness Tied to Earlier Onset of Alzheimer's DiseaseAHA News: Black, Hispanic Families Hit Hardest by DementiaWhy Some 'Super Ager' Folks Keep Their Minds Dementia-FreeDementia Seen in Younger Adults Shows Even More Brain Damage Than Alzheimer'sToo Little Sleep Could Raise Your Dementia RiskSpecialist Care for Alzheimer's Is Tough to Find for Poorer, Rural AmericansTony Bennett's Struggle With Alzheimer's RevealedFluid-Filled Spaces in the Brain Linked to Worsening MemoryCOVID Vaccine Advised for Alzheimer's Patients, Their CaregiversAphasia Affects Brain Similar to Alzheimer's, But Without Memory LossCaregivers Feeling the Strain This Tough Holiday SeasonYears Before Diagnosis, People With Alzheimer's Lose Financial AcumenCould Dirty Air Help Speed Alzheimer's?Strong Sleeping Pills Tied to Falls, Fractures in Dementia PatientsAnxiety Might Speed Alzheimer's: StudyPre-Op 'Brain Games' Might Prevent Post-Op DeliriumDoes Hard Work Help Preserve the Brain?Staying Active as You Age Not a Guarantee Against DementiaSmog Tied to Raised Risk for Parkinson's, Alzheimer's DiseasePoor Brain Blood Flow Might Spur 'Tangles' of Alzheimer'sIs Apathy an Early Sign of Dementia?A-Fib Treatment Reduces Patients' Dementia RiskFall Risk Rises Even in Alzheimer's Early StagesPTSD May Be Tied to Greater Dementia RiskNew Research Links Another Gene to Alzheimer's RiskIs Rural Appalachia a Hotspot for Alzheimer's?Why Are Dementia Patients Getting Risky Psychiatric Drugs?Get Dizzy When Standing Up? It Could Be Risk Factor for DementiaCan Seniors Handle Results of Alzheimer's Risk Tests?More Education May Slow Start of Early-Onset Alzheimer'sUnder 50 and Overweight? Your Odds for Dementia Later May Rise9/11 First Responders Have Higher Odds for Alzheimer's: StudyCould the Flu Shot Lower Your Risk for Alzheimer's?Will Your Brain Stay Sharp Into Your 90s? Certain Factors Are KeyMany Americans With Dementia Live in Homes With GunsBrain's Iron Stores May Be Key to Alzheimer'sHormones May Explain Greater Prevalence of Alzheimer's in WomenMiddle-Age Obesity Linked to Higher Odds for DementiaCould Crohn's, Colitis Raise Dementia Risk?5 Healthy Steps to Lower Your Odds for Alzheimer'sCOVID-19 Brings New Challenges to Alzheimer's CaregivingAlzheimer's Gene Linked to Severe COVID-19 RiskHealthier Heart, Better Brain in Old AgeAHA News: Hearing Loss and the Connection to Alzheimer's Disease, DementiaBrain Plaques Signal Alzheimer's Even Before Other Symptoms Emerge: StudyCertain Gene Might Help Shield At-Risk People From Alzheimer'sHow to Connect With Nursing Home Patients in QuarantineHow to Ease Loved Ones With Alzheimer's Through the PandemicCaring for Dementia Patient During Pandemic? Try These Stress-Busting Tips Questions and AnswersVideosLinksBook Reviews |
| |
Research and Prognosis on Alzheimer's DiseaseRudolph C. Hatfield, PhD., edited by Kathryn Patricelli, MATreatment Research
 At the time of this writing there are well over 100 different medications being investigated in research trials for treating Alzheimer's disease. These medications are at different stages in the research process and:
- The majority of these drugs are what are called modifying therapies. These are hoped to be able to change or alter how the disease progresses.
- A smaller number are cognitive enhancers. These are designed to improve cognitive functions like memory or attention.
- An even smaller number are symptomatic agents. This means that they just work on specific symptoms like agitation, hallucinations (seeing or hearing things that are not there), etc.
The process of approving drugs is often lengthy and consists of many steps. Initial steps are designed to test the safety of the drug. Then the next steps test to see if the drug works or does what it is supposed to do. The final two steps continue with evaluating its safety and effectiveness, as well as how it works when released on the market. Even though there are hundreds of drugs currently in development for Alzheimer's disease, it is a good bet that very few of them will get approval.
Other research that may assist in the development of treatment for Alzheimer's disease includes genetic research. This research is consistently uncovering new genetic associations that may lead to the development of Alzheimer's disease in some people. However, the path from understanding how a particular gene contributes to the development of the issues in Alzheimer's disease and in developing a medication to address that issue can take many years.
Prognosis
At the current time, there are only a few medications that are approved for the treatment of Alzheimer's disease. It is important to understand that these medications do not reverse or cure the disease. People who have Alzheimer's disease may live between one to twenty years after they are diagnosed with the disorder. The average length of time people live after the diagnosis is made is about eight years. However, there can be quite a bit of variation from person-to-person. Most often people with Alzheimer's disease die from other medical conditions that are complications of the disorder including pneumonia or from other factors such as heart disease.
|
